Central Bancompany heads into the week after its Q2 print with two analysts raising price targets on the same day — and the stock already up 37% year-to-date, trading comfortably above where the Street was pointing just months ago.
The catalyst is clear. Both Keefe, Bruyette & Woods and Piper Sandler revised targets higher on August 5, the day after CBC filed results. KBW's Christopher McGratty, maintaining a Market Perform, lifted his target from $29 to $32. Piper Sandler's Nathan Race, the more bullish of the two, pushed his Overweight target from $31 to $37. The consensus mean now sits at $33.70 against a close of $33.36 — a razor-thin gap that frames the Street debate succinctly: bulls think there's more runway, while the neutral camp sees fair value essentially here. Morgan Stanley had separately raised its Overweight target to $32 back in late June, so the direction of travel across all three active analysts has been uniformly upward. The bull case rests on NIM expansion — falling deposit costs, rising loan yields, and the potential for accretive M&A. The bear case is narrower: deposit growth has lagged loan growth, raising a quiet funding concern even as commercial banking continues to perform.
Borrow market conditions reinforce the low-conviction short thesis. Cost to borrow has collapsed from above 11% in early July to just 1.80% — a 70% drop in a week alone. That kind of rapid easing typically reflects shorts exiting or covering rather than fresh demand building. Short interest is running at roughly 2.2% of the free float, down about 1.6% on the week though up 13% over the past month from a lower base. Availability is generous at 223%, meaning more than two shares are available to borrow for every one currently lent out — a loose lending pool with no squeeze dynamics in view. The options market adds little drama: the put/call ratio of 0.14 is fractionally below its 20-day average, and the z-score of –0.85 places it well within normal range, suggesting no elevated demand for downside protection post-results.
Ownership is the defining structural feature of CBC. The top holders are almost entirely family names — Steven Cook, the Cook Family Trust, Sarah Tryhus, and related entities collectively control well over 30% of the shares. The float is therefore structurally constrained, which helps explain why short interest stays low and any borrow cost spikes tend to be brief. North Reef Capital Management is a notable institutional exception, having added 2.76 million shares as of March quarter-end, bringing its position to just over 4 million shares — the most significant institutional accumulation in the holder list.
Valuation has re-rated steadily alongside the price. The price-to-book multiple has expanded by roughly 0.06x over the past 30 days to sit near 1.84x, and the PE has moved up about 0.6 turns to 16.5x. Neither is stretched for a well-capitalised regional bank in the current rate environment, but the pace of re-rating means the margin of safety has narrowed. Peer performance this week was broadly constructive: GSBC gained 1.5%, PFBC added 1.7%, and CTBI rose 1.7% — all modestly trailing CBC's 2.8% weekly gain, which suggests the earnings catalyst added a few extra points of relative outperformance rather than the sector simply rising beneath it.
The ORTEX short score has held in a tight band around 63 for the past two weeks, reflecting the low-but-slowly-rising short interest against a loosening borrow market. The next scheduled earnings event is November 4 — the question between now and then is whether NIM expansion materialises at the pace the Overweight analysts expect, or whether deposit growth fails to keep pace with the loan book in the way the bear case describes.
See the live data behind this article on ORTEX.
Open CBC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
